News

Latest news

15th May 2019

Sequana Medical announces inclusion of alfapump® in German treatment guidelines (DGVS) for complications of liver cirrhosis

Read more
30th April 2019

Sequana Medical announces acceptance of late-breaking abstract of DSR therapy for volume overload in heart failure at Heart Failure 2019 Congress

Read more
1st March 2019

EditForce raises 870 million JPY

Read more
1st March 2019

エディットフォース株式会社　総額 8 億 7 千万円の資金調達完了について

Read more
8th February 2019

Sequana Medical raises €27.5 million in successful Initial Public Offering

Read more
7th February 2019

Sequana Medical announces the Coverage of the Base Offering of Its Initial Public Offering on Euronext Brussels

Read more
31st January 2019

Sequana Medical Launches Its Initial Public Offering on Euronext Brussels

Read more
29th January 2019

Sequana Medical receives Breakthrough Device designation from the FDA for its alfapump®

Read more
7th January 2019

株式会社日本政策投資銀行（DBJ）日欧アーリーステージ医薬品のベンチャーキャピタル Newton Biocapital I pricaf privée SAへの出資契約を締結

Read more